Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
30 - The developmental environment: experimental perspectives on skeletal development
Published online by Cambridge University Press: 08 August 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
Summary
Introduction
Osteoporosis is a multifactorial skeletal disorder characterised by low bone mass and microarchitectural deterioration of bony tissue, with a consequent increase in the risk of fracture (Jordan and Cooper 2002). The bone mass of an individual in later life depends upon the peak obtained during skeletal growth, and the subsequent rate of bone loss. Preventive strategies against osteoporotic fracture may be aimed at either increasing the peak bone mass attained or reducing the rates of bone loss. As shown in the previous chapter, epidemiological studies have indicated that poor growth during fetal life, infancy and childhood is associated with decreased bone mass in adulthood and an increased risk of fracture (Cooper et al. 1995, 1997, Fall et al. 1998). These relationships appear to be mediated through the programming of metabolic and endocrine systems governing bone growth, by environmental influences acting during critical periods of intrauterine or early postnatal development (Barker 1995, 2000, Barker and Martyn 1997, Godfrey and Barker 2001). In particular, maternal nutrition appears to be important in determining skeletal size at maturity. However, to date, there is little understanding of the cellular and molecular mechanisms whereby environmental modulation in utero could lead to an altered skeletal development among the offspring. This review will examine the benefits and information gained from animal models of intrauterine programming (maternal dietary modulation) with respect to the skeletal development of the young offspring, peak bone mass and bone quality of aged offspring, and will correlate to other animal studies undertaken ex utero and, as appropriate, to the human scenario.
- Type
- Chapter
- Information
- Developmental Origins of Health and Disease , pp. 406 - 414Publisher: Cambridge University PressPrint publication year: 2006
References
, , and (2001). Prenatal exposure to a maternal low protein diet shortens life span in rats. Gerontology, 47, 9–14.CrossRefGoogle ScholarPubMed
, , , and (2000). Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J. Bone Miner. Res., 15, 683–90.CrossRefGoogle ScholarPubMed
, , , and (1999). A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan bone mineral accrual study. J. Bone Miner. Res., 14, 1672–9.CrossRefGoogle ScholarPubMed
(1995). Intrauterine programming of adult disease. Mol. Med. Today, 1, 418–23.CrossRefGoogle ScholarPubMed
(2000). In utero programming of cardiovascular disease. Theriogenology, 53, 555–74.CrossRefGoogle ScholarPubMed
and (1997). The fetal origins of hypertension. Adv. Nephrol. Necker Hosp., 26, 65–72.Google ScholarPubMed
, , et al. (1994). Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate. Endocrinology, 135, 1367–71.CrossRefGoogle ScholarPubMed
, , and (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 19, 180–92.CrossRefGoogle ScholarPubMed
, , , and (2000a). Dietary protein deficiency induces osteoporosis in aged male rats. J. Bone Miner. Res., 15, 1555–63.CrossRefGoogle Scholar
, , and (2000b). Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats. Endocrinology, 141, 3149–55.CrossRefGoogle Scholar
, , and (1991). Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J. Orthop. Res., 9, 348–59.CrossRefGoogle ScholarPubMed
, , et al. (1999). Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J. Am. Soc. Nephrol., 10, 971–9.Google ScholarPubMed
, , et al. (1995). Childhood growth, physical activity, and peak bone mass in women. J. Bone Miner. Res., 10, 940–7.CrossRefGoogle ScholarPubMed
, , , , and (1997). Growth in infancy and bone mass in later life. Ann. Rheum. Dis., 56, 17–21.CrossRefGoogle ScholarPubMed
, , , , and (2001). Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos. Int., 12, 623–9.CrossRefGoogle ScholarPubMed
, , , , and, . (1998). Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis. J. Clin. Endocrinol. Metab., 83: 135–9.Google ScholarPubMed
, , and (2002). Volume increase in growth plate chondrocytes during hypertrophy: the contribution of organic osmolytes. Bone, 30, 574–81.CrossRefGoogle ScholarPubMed
and (2001). Fetal programming and adult health. Public Health Nutr., 4, 611–24.CrossRefGoogle ScholarPubMed
, , et al. (1999). BMP-6 is an autocrine stimulator of chondrocyte differentiation. J. Bone Miner. Res., 14, 475–82.Google Scholar
, and (1998). Chondrocyte apoptosis in development, aging and disease. Matrix Biol., 17, 107–15.CrossRefGoogle ScholarPubMed
and (1970). The assessment of skeletal maturity in the growing rat. J. Anat., 106, 371–402.Google ScholarPubMed
and (1989). Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J. Physiol., 414, 55–71.CrossRefGoogle ScholarPubMed
and (2002). Epidemiology of osteoporosis. Best Pract. Res. Clin. Rheumatol., 16, 795–806.CrossRefGoogle Scholar
(1973). Aspects of the maturation process in growth cartilage in the rat tibia. Clin. Orthop., 95, 288–94.Google Scholar
and (2001). The parathyroid hormone-related protein and Indian hedgehog feedback loop in the growth plate. Novartis. Found. Symp., 232, 144–52.Google ScholarPubMed
, and (1996). Relationship between bone growth rate and hypertrophic chondrocyte volume in New Zealand white rabbits of varying ages. J. Orthop. Res., 14, 706–11.CrossRefGoogle ScholarPubMed
and (1994). Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low-protein diets. Clin. Sci., 86, 217–22.CrossRefGoogle ScholarPubMed
, and (1996). Maternal protein restriction influences the programming of the rat hypothalamic–pituitary–adrenal axis. J. Nutr., 126, 1578–85.CrossRefGoogle ScholarPubMed
, and (1999a). Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci., 64, 965–74.CrossRefGoogle Scholar
, , , , and (1999b). Intrauterine programming of hypertension: the role of the reninangiotensin system. Biochem. Soc. Trans., 27, 88–93.CrossRefGoogle Scholar
, , et al. (2002). Intrauterine exposure to a maternal low protein diet reduces adult bone mass and alters growth plate morphology in rats. Calcif. Tissue Int., 71, 493–8.CrossRefGoogle ScholarPubMed
and (1999). Protein malnutrition affects the growth trajectories of the craniofacial skeleton in rats. J. Nutr., 129, 2061–9.CrossRefGoogle ScholarPubMed
, and (2000). Evidence of progressive deterioration of renal function in rats exposed to a maternal low-protein diet in utero. Br. J. Nutr., 83, 79–85.Google ScholarPubMed
, , , and (2003). Maternal protein deficiency affects mesenchymal stem cell activity in the developing offspring. Bone, 33, 100–7.CrossRefGoogle ScholarPubMed
and (2000). Bones, muscles and visceral organs of protein-malnourished rats (Rattus norvegicus) grow more slowly but for longer durations to reach normal final size. J. Nutr., 130, 2326–32.CrossRefGoogle ScholarPubMed
and (2000). Programmed cell death of chondrocytes in vivo: apoptosis, dark chondrocytes, and cell paralysis. In Chemistry and Biology of Mineralized Tissues: Proceedings of the Sixth International Conference (ed. , and ). Rosemont, IL, American Academy of Orthopedic Surgeons, pp. 325–30.Google Scholar
, , , and (2003a). Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physis. J. Histochem. Cytochem., 51, 373–83.CrossRefGoogle Scholar
, , and (2003b). Catabolic and anabolic phases of osteodystrophy in aged rats. J. Bone Miner. Metab., 21, 299–306.CrossRefGoogle Scholar
, and (2004). Chondroptosis: a variant of apoptotic cell death in chondrocytes?Apoptosis, 9, 265–77.CrossRefGoogle ScholarPubMed
, , and (2001). Glucocorticoids, thyroid hormone and growth hormone interactions: implications for the growth plate. Horm. Res., 56 (Suppl 1), 7–12.Google ScholarPubMed
Triffitt, J. T. and Oreffo, R. O. C. (1998). The osteoblast lineage In Molecular and Cellular Biology of Bone (ed. ) Advances in Organ Biology, vol. 5B. Stamford, CT: JAI Press. pp. 429–51.Google Scholar
, , and (1982). Postnatal growth of intrauterine growth retarded infants. Early Hum. Dev., 6, 265–71.CrossRefGoogle ScholarPubMed
, , , and (1984). Heterogeneous growth and mental development of intrauterine growth-retarded infants during the first 3 years of life. Pediatrics, 74, 783–91.Google ScholarPubMed
, and (1981). Skeletal maturity at birth and at the age of 3 years of infants malnourished in utero. Early Hum. Dev., 5, 139–43.CrossRefGoogle ScholarPubMed
and (1963). The effect of finite periods of undernutrition at different ages on the composition and subsequent development of the rat. Proc. R. Soc. Lond. B, 158, 329–42.CrossRefGoogle ScholarPubMed
, , , and (1996). Cell cycle analysis of proliferating zone chondrocytes in growth plates elongating at different rates. J. Orthop. Res., 14, 562–72.CrossRefGoogle ScholarPubMed